AU2011209004B2 - Phenyl C-glucoside derivatives, preparation methods and uses thereof - Google Patents

Phenyl C-glucoside derivatives, preparation methods and uses thereof Download PDF

Info

Publication number
AU2011209004B2
AU2011209004B2 AU2011209004A AU2011209004A AU2011209004B2 AU 2011209004 B2 AU2011209004 B2 AU 2011209004B2 AU 2011209004 A AU2011209004 A AU 2011209004A AU 2011209004 A AU2011209004 A AU 2011209004A AU 2011209004 B2 AU2011209004 B2 AU 2011209004B2
Authority
AU
Australia
Prior art keywords
compound
pharmaceutically acceptable
general formula
acid
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011209004A
Other languages
English (en)
Other versions
AU2011209004A1 (en
Inventor
Bingni Liu
Wei Liu
Hua Shao
Chubing Tan
Lida Tang
Yuli Wang
Weiren Xu
Shijun Zhang
Guilong Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Institute of Pharmaceutical Research Co Ltd
Original Assignee
Tianjin Institute of Pharmaceutical Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Institute of Pharmaceutical Research Co Ltd filed Critical Tianjin Institute of Pharmaceutical Research Co Ltd
Publication of AU2011209004A1 publication Critical patent/AU2011209004A1/en
Application granted granted Critical
Publication of AU2011209004B2 publication Critical patent/AU2011209004B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2011209004A 2010-01-26 2011-01-14 Phenyl C-glucoside derivatives, preparation methods and uses thereof Ceased AU2011209004B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201010101146 2010-01-26
CN201010101146.7 2010-01-26
CN2010105223370A CN102134226B (zh) 2010-01-26 2010-10-27 一类苯基c-葡萄糖苷衍生物、其制备方法和用途
CN201010522337.0 2010-10-27
PCT/CN2011/000061 WO2011091710A1 (zh) 2010-01-26 2011-01-14 苯基c-葡萄糖苷衍生物、其制备方法和用途

Publications (2)

Publication Number Publication Date
AU2011209004A1 AU2011209004A1 (en) 2012-09-06
AU2011209004B2 true AU2011209004B2 (en) 2015-04-30

Family

ID=44294177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011209004A Ceased AU2011209004B2 (en) 2010-01-26 2011-01-14 Phenyl C-glucoside derivatives, preparation methods and uses thereof

Country Status (7)

Country Link
US (1) US9062087B2 (de)
EP (1) EP2530079A4 (de)
JP (1) JP2013518065A (de)
KR (1) KR20120107526A (de)
CN (1) CN102134226B (de)
AU (1) AU2011209004B2 (de)
WO (1) WO2011091710A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675378A (zh) * 2011-03-09 2012-09-19 天津药物研究院 一类含环丙烷结构的c-葡萄糖苷衍生物、其制备方法和用途
CN102757415B (zh) * 2011-04-25 2015-07-29 北京普禄德医药科技有限公司 一种钠依赖性葡萄糖转运蛋白抑制剂及其制备方法和用途
CN102827122B (zh) * 2011-06-17 2015-01-14 山东轩竹医药科技有限公司 糖苷衍生物
CN102408459B (zh) * 2011-09-29 2014-07-23 天津药物研究院 一类含异头位烷基的苯基c-葡萄糖苷衍生物、其制备方法和用途
CN103058972B (zh) * 2013-01-17 2014-12-10 天津药物研究院 一类含环己烷结构的苯基c-葡萄糖苷衍生物、其制备方法和用途
ES2786901T3 (es) * 2013-03-11 2020-10-14 Janssen Pharmaceutica Nv Inhibidores SGLT1/SGLT2 duales
CN104418830A (zh) * 2013-09-10 2015-03-18 天津药物研究院 (1s)-1,6-二脱氧-1-[4-甲氧基-3-(反式-4-正丙基环己基)甲基苯基]-d-葡萄糖的制备工艺
US9394329B2 (en) 2013-09-27 2016-07-19 Sunshine Lake Pharma Co., Ltd. Glucopyranosyl derivatives and their uses in medicine
CN103739581B (zh) * 2014-01-23 2016-11-23 中国药科大学 C-芳基葡萄糖苷sglt2抑制剂
CN104860793A (zh) * 2014-02-20 2015-08-26 天津药物研究院 一类苯基c-葡萄糖苷衍生物中间体的制备方法
CN105753910A (zh) * 2014-12-16 2016-07-13 康普药业股份有限公司 一种卡格列净中间体的制备方法
RU2739024C2 (ru) 2016-01-04 2020-12-21 Че Иль Фармасьютикал Ко., Лтд. С-гликозидные производные, содержащие конденсированное фенильное кольцо, или их фармацевтически приемлемые соли, способ получения таковых и фармацевтическая композиция, содержащая таковые
ES2926403T3 (es) * 2016-08-09 2022-10-25 Laurus Labs Ltd Nuevos procedimientos para la preparación de dapagliflozina o sus solvatos o co-cristales de la misma
US20180203457A1 (en) * 2017-01-13 2018-07-19 Ford Global Technologies, Llc System and Method for Avoiding Interference with a Bus
WO2018207111A1 (en) 2017-05-09 2018-11-15 Piramal Enterprises Limited A process for the preparation of sglt2 inhibitors and intermediates thereof
CN107163092B (zh) * 2017-06-13 2020-05-19 杭州科巢生物科技有限公司 Sglt-2糖尿病抑制剂及其中间体的制备方法
CN110141566B (zh) * 2018-02-11 2022-04-19 清华大学深圳研究生院 Sglt2抑制剂在调控炎症中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004359630A (ja) * 2003-06-06 2004-12-24 Yamanouchi Pharmaceut Co Ltd ジフルオロジフェニルメタン誘導体及びその塩
WO2005012326A1 (en) * 2003-08-01 2005-02-10 Tanabe Seiyaku Co., Ltd. Novel compounds having inhibitory activity against sodium-dependant transporter

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
TWI254635B (en) * 2002-08-05 2006-05-11 Yamanouchi Pharma Co Ltd Azulene derivative and salt thereof
WO2004080990A1 (ja) * 2003-03-14 2004-09-23 Astellas Pharma Inc. Ｃ－グリコシド誘導体又はその塩
US7129220B2 (en) * 2003-08-01 2006-10-31 Janssen Pharmaceutica N.V Substituted indole-O-glucosides
AR051446A1 (es) 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
WO2006035796A1 (ja) * 2004-09-29 2006-04-06 Kissei Pharmaceutical Co., Ltd. １－（β－Ｄ－グリコピラノシル）－３－置換含窒素ヘテロ環化合物、それを含有する医薬組成物及びその医薬用途
DE102004048388A1 (de) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
AU2008232419B2 (en) * 2007-04-02 2013-06-20 Theracos, Inc. Benzylic glycoside derivatives and methods of use
JP4809931B2 (ja) * 2007-08-23 2011-11-09 セラコス・インコーポレイテッド ベンジルベンゼン誘導体およびその使用方法
CN101503399B (zh) * 2008-02-04 2012-06-27 白鹭医药技术（上海）有限公司 C-芳基葡萄糖苷sglt2抑制剂
JP6071198B2 (ja) * 2008-07-15 2017-02-01 テラコス，インコーポレーテッド 重水素化ベンジルベンゼン誘導体及び使用方法
US8163704B2 (en) * 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004359630A (ja) * 2003-06-06 2004-12-24 Yamanouchi Pharmaceut Co Ltd ジフルオロジフェニルメタン誘導体及びその塩
WO2005012326A1 (en) * 2003-08-01 2005-02-10 Tanabe Seiyaku Co., Ltd. Novel compounds having inhibitory activity against sodium-dependant transporter

Also Published As

Publication number Publication date
AU2011209004A1 (en) 2012-09-06
EP2530079A1 (de) 2012-12-05
WO2011091710A1 (zh) 2011-08-04
CN102134226B (zh) 2013-06-12
CN102134226A (zh) 2011-07-27
KR20120107526A (ko) 2012-10-02
US20130023486A1 (en) 2013-01-24
US9062087B2 (en) 2015-06-23
EP2530079A4 (de) 2013-06-19
JP2013518065A (ja) 2013-05-20

Similar Documents

Publication Publication Date Title
AU2011209004B2 (en) Phenyl C-glucoside derivatives, preparation methods and uses thereof
ES2358051T3 (es) Formas cristalinas de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno, métodos para su preparación y su uso para preparar medicamentos.
CA2977109C (en) Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof
ES2337127T3 (es) Nuevos derivados de pirazol y remedios contra la diabetes que los contienen.
ES2316650T3 (es) Polimorfos de hidrogenosulfato de clopidogrel.
ES2062450T4 (es) Sales metálicas bivalentes del ácido n,n-di(carboximetil)-2-amino-3-ciano-4-carboximetil-5-carboxi-tiofeno y su procedimiento de preparacion.
CN104761522B (zh) 光学纯的苄基‑4‑氯苯基的c‑糖苷衍生物
ZA200302283B (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same.
JP6309566B2 (ja) デオキシグルコース構造を有するフェニルｃ−グルコシド誘導体、その調製方法および使用方法
KR20140004783A (ko) 소듐-의존적 포도당 운반 단백질의 억제제 및 이의 제조방법 및 용도
WO2013000275A1 (zh) C-糖苷衍生物
JP6461080B2 (ja) 二重ｓｇｌｔ１／ｓｇｌｔ２阻害剤
WO2014146494A1 (zh) β-氨基羰基类化合物、其制备方法、药物组合物及其用途
WO2011095050A1 (zh) 含饱和六元环的c-葡萄糖苷衍生物、其制备方法和用途
US5747521A (en) N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same
WO2014139447A1 (zh) (1s)-1-[4-氯-3-(4-乙氧基苄基)苯基]-1,6-二脱氧-d-葡萄糖的晶型a及其制备方法和应用
WO2012119550A1 (zh) 含环丙烷结构的c-葡萄糖苷衍生物及其制备方法、药物组合物和用途
ES2219419T3 (es) Derivados de beta-d-5-tioxilosa, procedimiento de preparacion y utilizacion en terapeutica.
CN114149395A (zh) 一种苯并环戊烯酮衍生物、其制备方法及医药用途
CN106674245B (zh) 吡喃葡萄糖基衍生物的制备及医药上的应用
JPH01228928A (ja) リグナン類およびリグナン類を有効成分とする抗腫瘍剤
CN103739575B (zh) 14-脱氧-11,12-二脱氢穿心莲内酯衍生物及其药物组合物和应用
CN104230932A (zh) 苦参碱衍生物及其制备方法与应用
CN110551088B (zh) 氘修饰的苄基-4-氯苯基的c-糖苷衍生物
KR102283835B1 (ko) 케르세틴 유도체, 이를 포함하는 암 예방 또는 치료용 약학적 조성물 및 이의 합성 방법

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired